Guangzhou Baiy | 600332 - Selling And Administration Expenses


Guangzhou Baiy reported CNY1.75B in Selling and Administration Expenses for its fiscal quarter ending in September of 2025.





Selling And Administration Expenses Change Date
Aspen Pharmacare ZAR 5.62B 252M Jun/2025
Cipla INR 13.25B 101.8M Dec/2025
Dr.Reddys Laboratories INR 26.92B 482M Dec/2025
Jiangsu Hengrui CNY 3.23B 111.82M Sep/2025
Kalbe Farma IDR 2.51T 410.17B Sep/2025
Richter Gedeon HUF 52.3B 1.18B Sep/2025
Sh Fosun Pharma CNY 3.12B 22.02M Sep/2025
Sh Pharmaceutical CNY 4.66B 4.3B Sep/2025
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
Teva Pharmaceutical Industries USD 1.12B 147M Dec/2025